top of page
Promising Breakthrough in Ovarian Cancer Treatment: Merck's Positive Phase 3 Trial Results
Merck has announced a significant step forward in ovarian cancer research with the successful results of its Phase 3 KEYLYNK-001 trial ,...
The Female Body
Dec 12, 20243 min read
0 views
0 comments
bottom of page